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Abstract
Unobserved confounding is a well known threat to causal inference in non-experimental studies.
The instrumental variable design can under certain conditions be used to recover an unbiased
estimator of a treatment e¤ect even if unobserved confounding cannot be ruled out with certainty.
For continuous outcomes, two stage least squares is the most common instrumental variable esti-
mator used in epidemiologic applications. For a rare binary outcome, an analogous linear-logistic
two-stage procedure can be used. Alternatively, a control function approach is sometimes used
which entails entering the residual from the rst stage linear model as a covariate in a second
stage logistic regression of the outcome on the treatment. Both strategies for binary response have
previously formally been justied only for continuous exposure, which has impeded widespread use
of the approach outside of this setting. In this note, we consider the important setting of binary
exposure in the context of a binary outcome. We provide an alternative motivation for the control
function approach which is appropriate for binary exposure, thus establishing simple conditions
under which the approach may be used for instrumental variable estimation when the outcome is
rare. In the proposed approach, the rst stage regression involves a logistic model of the exposure
conditional on the instrumental variable, and the second stage regression is a logistic regression
of the outcome on the exposure adjusting for the rst stage residual. In the event of a non-rare
outcome, we recommend replacing the second stage logistic model with a risk ratio regression.
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In recent years, the instrumental variable (IV) design has gained popularity in epidemiology, as a
strategy to recover unbiased estimates of an exposure or treatment causal e¤ect in settings where
unobserved confounding is suspected to be present (Greenland, 2000, Davey Smith and Ebrahim,
2003, Hernán and Robins, 2006, Lawlor et al, 2008, Palmer et al, 2011). For continuous outcomes,
the most common IV estimator used in practice is two stage least squares which involves tting a
linear regression of the outcome on an estimate of the exposure mean, obtained by regressing the
exposure on the IV in a rst stage linear model (Wooldridge, 2002). For a rare binary outcome
an analogous two stage procedure is sometimes used, in which linear regression is used in the rst
stage, however, a logistic regression is substituted in the second stage to account for the binary
nature of the outcome (Theil, 1953, Basmann, 1957, Angrist, 2001, Wooldridge, 2002, Didelez
et al, 2010). A variation of the approach simply adjusts for the residual of the rst stage linear
regression of the exposure, in a second stage logistic regression of the outcome on the observed
treatment; this strategy is described in the literature as a control function approach (Garen, 1994,
Woldridge, 1997, Nagelkerke et al, 2000, Blundell and Powell, 2003, Terza et al, 2008). Both
strategies for binary response have previously formally been justied only for continuous exposure
(Mullahy,1997, Didelez, 2010, Vansteelandt et al, 2011), which has impeded widespread application
of either method outside of this setting. In this note, we consider the important setting of binary
treatment in the context of a binary outcome. We provide an alternative formulation of the second
strategy which applies for binary exposure, thus establishing simple conditions under which the
approach may be used for instrumental variable estimation when the outcome is rare and the
treatment is binary. In the proposed control function approach, the rst stage regression involves
a logistic model of the exposure conditional on the instrumental variable, and the second stage
regression is a logistic regression of the outcome on the exposure adjusting for the rst stage
residual. In the event of a non-rare outcome, we recommend replacing the second stage with a risk
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ratio regression.
Review of control function for continuous treatment
Suppose that one has observed a rare binary outcome Y , a continuous exposure A; and a binary
instrumental variable Z. Throughout, U will refer to an unmeasured continuous confounder of
the A-Y causal association. A standard formulation of a data generating model for the control
function approach assumes the outcome is generated from the log linear model
log Pr (Y = 1jA;Z; U) = 0 + AA+ U; (1)
with A the log risk ratio causal association between A and Y conditional on U (see for example
Palmer et al, 2011): The model rules out the possibility of latent e¤ect heterogeneity of A wrt U
on the multiplicative scale. For continuous A, the model further posits the following model for
the exposure :
A = 0 + 1Z + 2U + " where " is independent mean zero error, (2)
where 2 6= 0. In addition the model assumes that U and Z are independent, as would be the
case for a valid IV. Note that the above model encodes explicitly the assumption that Z is a valid
instrumental variable, which satises the following conditions:
1. Z only a¤ect Y through its association with A; which is encoded by the fact that although
Z appears in the conditioning event on the left hand side of equation (1) ; it does not appear
on the right hand side of the equation.
2. The unmeasured confounder of the exposure e¤ect on the outcome is independent of the IV,
thus Z is independent of U .
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3. The IV is relevant for the exposure, i.e. Z predicts A and thus 1 6= 0:
Note that this formulation assumes U does not interact with Z in the model for A: Under these
assumptions, one can show that
log Pr(Y = 1jA;Z) = 0 + AA+ 1
where
 = A  E (AjZ) :
The above equation gives a simple parametrization for the log-linear regression of Y on (A;Z),
which allows one to recover under the stated assumptions, the causal log risk ratio association
A between A and Y . Estimation typically proceeds in two stages. In the rst stage, one ts a
standard linear regression to estimate the exposure model
E (AjZ) = 0 + 1Z
by ordinary least squares (ols), which in turn is used to estimate the residual  with b =
A   (b0 + b1Z) ; where (b0; b1) are ols estimates. Then in a second stage, one regresses Y
on (A; b) using standard logistic regression, as a suitable approximation for the log-linear model
(4) : The regression coe¢ cient for the exposure in the second stage logistic regression will then
be approximately unbiased for A. We will refer to the above two stage procedure as the linear-
logistic control function approach. The large sample variance of the resulting estimator of A
must acknowledge the rst stage estimation of E (AjZ) ; which is easily obtained from standard
M-estimation theory. Alternatively, when convenient, one could also use the nonparametric boot-
strap to obtain condence intervals.
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One can assess the extent of unobserved confounding, by evaluating the strength of association
between Y and ; which can be performed with a test of the null hypothesis that 1 = 0:
Control function for binary treatment
Now, suppose that A is dichotomous, then as noted by Didelez et al (2010), assumption (2)
cannot be satised for binary exposure. Thus, we will consider an alternative formulation, whereby
assumption (2) is replaced by the following location shift model for U :
U = E (U jA;Z) +  where  is independent of (A;Z) (3)
The assumption would hold if U were normally distributed given (A;Z) with homoscedastic
variance, however, this is not strictly required and the model allows for an arbitrary distribution
for :
Result 1: Under assumptions (1),(3) ; and the assumption that U and Z are independent, we have
that,
log Pr(Y = 1jA;Z) = 0 + AA+ (!1 + !2Z) ; (4)
where (0 ; !1; !2) are dened in the appendix.
Result 1 provides formal justication for a generalization of the control function approach in the
context of a binary treatment, with the standard control function approach recovered by setting
!2 = 0: Interestingly, unlike the standard formulation for continuous treatment, the regression
model (4) formally allows for heterogeneity in the degree of selection bias due to confounding if
!2 6= 0:
Implementation of the approach in practice is fairly straightforward. The main adjustment to
account for binary treatment is in the rst stage estimation of the treatment model, whereby ols
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estimation of a linear model for continuous treatment can be replaced with maximum likelihood
estimation (mle) of a logistic regression for binary treatment:
logitPr (A = 1jZ) = 0 + 1Z
to produce an estimated propensity score b(Z) = cPr (A = 1jZ) using the mle (b0; b1) : The second
stage of the approach proceeds by estimating the logistic regression of Y on (A; b; Z b) , upon
redening the estimated residual as b = A   b(Z): The resulting estimator of the regression
coe¢ cient for the exposure in the second stage logistic regression will be approximately unbiased
for A provided that the assumptions of Result 1 hold. For inference, one may use M-estimation
theory to derive the large sample variance of the estimator, alternatively, one can proceed with
the nonparametric bootstrap.
Control function when the outcome is not rare
If Y is not rare in the target population, one may adopt one of several existing methods to estimate
the risk ratio regression (4), including the log-binomial model of Wacholder (1986), the Poisson
regression approach of Zou (2004), and the semiparametric locally e¢ cient approach of Tchetgen
Tchetgen (2013).
Control function under case-control sampling
Case-control studies are a common design in epidemiologic practice, particularly is settings where Y
is rare in the population, or measuring Z or A is costly. Accounting for case-control ascertainment
is fairly straightforward in the case of a rare outcome, since logistic regression, which appropriately
accounts for the sampling design can continue to be used in the second stage, however, the rst
stage regression model must be modied to account for possible selection bias. A simple strategy
entails restricting estimation of the rst stage regression of A on Z, to the subset of controls with
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Y = 0; which should yield a reasonable approximation of the population regression model. This
approach may however be ine¢ cient, since it does not make use of the exposure and IV measured
among cases. Under certain assumptions, it may be possible to improve the e¢ ciency of the rst
stage regression which in turn may lead to a more e¢ cient second stage estimator of the treatment
e¤ect. This can be achieved by using all available information on both cases and controls, and by
adjusting for case-control status in estimating the rst stage regression model. For instance, for
continuous A; one may modify the rst stage regression and instead estimate:
E(AjZ; Y ) = 0 + 1Z + 2Y;
which involves adjusting for ascertainment by directly conditioning on case-control status in the
regression model. Under the rare disease assumption, the above model would in principle recover
an unbiased estimator (e0; e1) of (0; 1) provided the degree of ascertainment bias (here encoded
by a non-null value of 2) does not vary with Z (Tchetgen Tchetgen et al, 2013, Tchetgen Tchetgen,
2013b): It is important to note that some care is needed in forming the residual used in the second
stage logistic regression, which must reect the residual value for A in the underlying population
and is therefore obtained by evaluating the predicted mean of A under the above estimated mean
model, after setting Y = 0 for both cases and controls (Tchetgen Tchetgen et al, 2013), i.e.
b = A  bE(AjZ; Y = 0) = A  e0   e1Z
Tchetgen Tchetgen (2013b) discusses analogous methodology to account for possible hetero-
geneity in the degree of selection bias, and similar techniques are also developed in the context of
logistic regression for binary A; and are likewise extended to account for case-control ascertainment
when Y is not necessarily rare in the population. However, similar to standard inverse probability
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weighting, which may also be used to account for the sampling design (although it may be rela-
tively ine¢ cient), the sampling fractions for cases and controls must be available to account for
sampling conditional on an outcome Y which may not be rare in the target population (Tchetgen
Tchetgen, 2013b).
Adjusting for covariates
Here we consider a straightforward generalization to allow for the presence of covariates C such
that Z is a valid IV conditional on C but not necessarily so upon marginalizing over any component
of C. Assuming standard prospective sampling, in order to incorporate such covariates, it su¢ ces
to modify regression models used in the rst and second stages, such that in the case of continuous
exposure, the rst stage regression further adjusts for C; e.g.
E(AjZ;C) = 0 + 1Z + 2C;
and likewise, for binary A; one could specify
logitPr(A = 1jZ;C) = 0 + 1Z + 2C:
The second stage regression in the rare outcome situation could also be modied accordingly, e.g.
logitPr(Y = 1jA;Z) = 0 + 0CC + AA+ (1 + 2Z) b
with b the estimated residual A   bE(AjZ;C); and analogous adjustments can be made to the
risk ratio regression approach recommended for non-rare outcomes, as well as under case-control
sampling.
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Conclusion
In this note, an alternative framework is proposed to motivate the control function IV approach
in the context of binary outcome, with binary treatment. Although emphasis is given to binary
treatment, the approach can be modied to handle other types of discrete treatment, without
much di¢ culty. The approach can also be used with a continuous IV without further di¢ culty. In
addition, unlike available formulations of the control function approach, the proposed framework
allows for the presence of heterogeneity in the magnitude of selection bias (on the risk ratio
scale) with respect to the IV. Such heterogeneity may reect latent heterogeneity in the degree of
association of the IV with the treatment, the presence of which cannot be ruled out with certainty
in practice. Ignoring such heterogeneity when present may invalidate the commonly used control
function approach, and therefore the proposed framework is recommended for routine use as a
more robust alternative strategy for IV estimation in the context of binary outcome and binary
treatment.
Appendix
Proof of Result 1: Note that
Pr (Y = 1jA;Z) = E [exp (0 + AA+ U) jA;Z]
= exp (0 + AA)E [exp (U) jA;Z]
= exp (0 + AA+ logE [exp ()])
 exp fE (U jA;Z)g :
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Further note that
E (U jA;Z) = E (U jA;Z)  E (U jA = 0; Z)
 
Z
fE (U ja; Z)  E (U jA = 0; Z)g dF (ajZ)
+ E (U jZ)
= !1A+ !2AZ   1E (AjZ)  2E (AjZ)Z
+ E (U)
where
!1 = E (U jA = 1; Z = 0)  E (U jA = 0; Z = 0)
and
!2 = E (U jA = 1; Z = 1)  E (U jA = 0; Z = 1)
  fE (U jA = 1; Z = 0)  E (U jA = 0; Z = 0)g
therefore
Pr(Y = 1jA;Z) = exp f0 + AA+ (!1 + !2Z) g
where
0 = 0 + logE [exp ()] + E (U)
proving the result.
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